$7.11
0.101.43%
最終更新: Aug 21, 9:29 AM
Benzinga
Benzinga
Benzinga
金曜日, 8 21
Foghorn Therapeutics Inc
FHTXNASDAQ
Foghorn Therapeutics Earnings & Forecasts
Foghorn Therapeutics (FHTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Foghorn Therapeutics Guidance
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.23 | $-0.31 | $-0.27 | $-0.30 |
| Actual | $-0.10 | $-0.29 | $-0.34 | $-0.25 |
| Surprise | +56.5% | +6.45% | -25.9% | +16.7% |
| Revenue | ||||
| Estimate | $8.0M | $8.2M | $8.9M | $6.9M |
| Actual | $16.1M | $3.3M | $9.2M | $8.2M |
| Surprise | +101.6% | -60.2% | +3.32% | +17.4% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.24 | $-0.23 | $-0.20 | $-0.14 |
| Revenue | ||||
| Consensus | $8.1M | $8.6M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved